Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-221.15%
operating margin TTM
-1197.74%
revenue TTM
N/A
revenue per share TTM
0.0$
valuation ratios | |
|---|---|
| pe ratio | -9.03 |
| peg ratio | -0.18 |
| price to book ratio | -36.99 |
| price to sales ratio | 18.02 |
| enterprise value multiple | -25.24 |
| price fair value | -36.99 |
profitability ratios | |
|---|---|
| gross profit margin | 4.32% |
| operating profit margin | -1197.74% |
| pretax profit margin | -221.15% |
| net profit margin | -221.15% |
| return on assets | -21.26% |
| return on equity | 449.27% |
| return on capital employed | -159.85% |
liquidity ratios | |
|---|---|
| current ratio | 1.62 |
| quick ratio | 0.90 |
| cash ratio | 0.76 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 876.93 |
| operating cycle | 921.65 |
| days of payables outstanding | 455.89 |
| cash conversion cycle | 465.76 |
| receivables turnover | 8.16 |
| payables turnover | 0.80 |
| inventory turnover | 0.42 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.33 |
| debt equity ratio | -6.28 |
| long term debt to capitalization | 1.21 |
| total debt to capitalization | 1.19 |
| interest coverage | -9.88 |
| cash flow to debt ratio | -2.58 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.49 |
| cash per share | 0.12 |
| operating cash flow per share | -0.49 |
| free cash flow operating cash flow ratio | 1.01 |
| cash flow coverage ratios | -2.58 |
| short term coverage ratios | -28.80 |
| capital expenditure coverage ratio | -113.08 |
Frequently Asked Questions
When was the last time Humacyte, Inc. (NASDAQ:HUMA) reported earnings?
Humacyte, Inc. (HUMA) published its most recent earnings results on 12-11-2025.
What is Humacyte, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Humacyte, Inc. (NASDAQ:HUMA)'s trailing twelve months ROE is 449.27%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Humacyte, Inc. (HUMA) currently has a ROA of -21.26%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did HUMA's net profit margin stand at?
HUMA reported a profit margin of -221.15% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is HUMA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.62 in the most recent quarter. The quick ratio stood at 0.90, with a Debt/Eq ratio of -6.28.